← Leaderboards
Jeff Martini
Palvella Therapeutics, Inc.
$1,128,394
Attributed
$1,128,394
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $648.8K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
FDA$1,128,394 · 1
By mechanism
R01$1,128,394 · 1
Top collaborators
No co-investigators on record.
Grant awards (2)
SELVA: A Multicenter, Phase 3 Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 in the Treatment of Microcystic Lymphatic Malformations$648,834
R01 · FY2025 · FD · contact PI
SELVA: A Multicenter, Phase 3 Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 in the Treatment of Microcystic Lymphatic Malformations$479,560
R01 · FY2024 · FD · contact PI